C22H28N2O2
Neat
352.48
1688-76-2; Doxapram impurity B; 1-Ethyl-4-(2-((2-hydroxyethyl)amino)ethyl)-3, 3-diphenylpyrrolidin-2-one; UNII-73P6569O4H; 73P6569O4H; Doxapram hydrochloride impurity B [EP]; (+/-)-1-Ethyl-4-(2-((2-hydroxyethyl)amino)ethyl)-3, 3-diphenylpyrrolidin-2-one; (4RS)-1-Ethyl-4-(2-((2-hydroxyethyl)amino)ethyl)-3, 3-diphenylpyrrolidin-2-one; 2-Pyrrolidinone, 1-ethyl-4-(2-((2-hydroxyethyl)amino)ethyl)-3, 3-diphenyl-; 1-ethyl-4-[2-(2-hydroxyethylamino)ethyl]-3, 3-diphenylpyrrolidin-2-one; 2-Pyrrolidinone, 1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3, 3-diphenyl-; Doxapram EP impurity B; Doxapram impurity B CRS; DB-337201; DOXAPRAM HYDROCHLORIDE IMPURITY B [EP IMPURITY]; Q27266200; 1-ETHYL-4-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-3 and 3-DIPHENYL-PYRROLIDINONE
1-ethyl-4-[2-(2-hydroxyethylamino)ethyl]-3 and 3-diphenylpyrrolidin-2-one
InChI=1S/C22H28N2O2/c1-2-24-17-20(13-14-23-15-16-25)22(21(24)26,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,20,23,25H,2,13-17H2,1H3